David A. D’Alessio

1. Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS‐CVOT design and baseline characteristics
   2023/09/25 by Stephen J. Nicholls, Deepak L. Bhatt, Deepak L Bhatt +29 · 33 citations
   Medicine · #Diabetes Treatment and Management #Hyperglycemia and glycemic control in critically ill and hospitalized patients #Diabetes, Cardiovascular Risks, and Lipoproteins
2. 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
   2019/12/19 by John B. Buse, Deborah J. Wexler, Απόστολος Τσάπας +6 · 3 citations
   Biochemistry, Genetics and Molecular Biology · Medicine · #Diabetes Management and Research #Diabetes Treatment and Management #Metabolism, Diabetes, and Cancer
3. GLP-1 receptor agonists and diabetic retinopathy: A meta-analysis of randomized clinical trials
   2023/07/16 by Ishani Kapoor, Swara M. Sarvepalli, David A. D’Alessio +3 · 1 citation
   Medicine · #Diabetes Treatment and Management #Pancreatic function and diabetes #Diabetes Management and Research